Literature DB >> 33502386

Response to: 'Nodding syndrome, many questions remain but we can prevent it by eliminating onchocerciasis'.

Sam Olum1, Peter Scolding2, Charlotte Hardy1,3, James Obol1, Neil J Scolding1,4.   

Abstract

Entities:  

Year:  2021        PMID： 33502386      PMCID： PMC7811753          DOI： 10.1093/braincomms/fcaa229

Source DB:  PubMed          Journal:  Brain Commun        ISSN： 2632-1297


× No keyword cloud information.
  11 in total

1.  Changes in epilepsy burden after onchocerciasis elimination in a hyperendemic focus of western Uganda: a comparison of two population-based, cross-sectional studies.

Authors:  Nolbert Gumisiriza; Christoph Kaiser; George Asaba; Henry Onen; Frank Mubiru; Donozio Kisembo; Joseph Nelson Siewe Fodjo; Robert Colebunders
Journal:  Lancet Infect Dis       Date:  2020-06-26       Impact factor: 25.071

Review 2.  Ivermectin: panacea for resource-poor communities?

Authors:  Satoshi Omura; Andy Crump
Journal:  Trends Parasitol       Date:  2014-08-12

3.  Nodding syndrome may be an autoimmune reaction to the parasitic worm Onchocerca volvulus.

Authors:  Tory P Johnson; Richa Tyagi; Paul R Lee; Myoung-Hwa Lee; Kory R Johnson; Jeffrey Kowalak; Abdel Elkahloun; Marie Medynets; Alina Hategan; Joseph Kubofcik; James Sejvar; Jeffrey Ratto; Sudhir Bunga; Issa Makumbi; Jane R Aceng; Thomas B Nutman; Scott F Dowell; Avindra Nath
Journal:  Sci Transl Med       Date:  2017-02-15       Impact factor: 17.956

4.  Modulation of monomethylhydrazine-induced seizures by ivermectin.

Authors:  T W Mayer; M L Horton
Journal:  Toxicol Lett       Date:  1991-07       Impact factor: 4.372

5.  Clinical picture, epidemiology and outcome of Loa-associated serious adverse events related to mass ivermectin treatment of onchocerciasis in Cameroon.

Authors:  Michel Boussinesq; Jacques Gardon; Nathalie Gardon-Wendel; Jean-Philippe Chippaux
Journal:  Filaria J       Date:  2003-10-24

6.  From river blindness to river epilepsy: Implications for onchocerciasis elimination programmes.

Authors:  Robert Colebunders; Joseph Nelson Siewe Fodjo; Adrian Hopkins; An Hotterbeekx; Thomson L Lakwo; Akili Kalinga; Makoy Yibi Logora; Maria-Gloria Basáñez
Journal:  PLoS Negl Trop Dis       Date:  2019-07-18

Review 7.  Onchocerciasis-associated epilepsy: From recent epidemiological and clinical findings to policy implications.

Authors:  Robert Colebunders; Alfred K Njamnshi; Marieke van Oijen; Deby Mukendi; Jean Marie Kashama; Michel Mandro; Nolbert Gumisiriza; Pierre-Marie Preux; Patrick Suykerbuyk; Richard Idro
Journal:  Epilepsia Open       Date:  2017-04-26

8.  Onchocerca volvulus is not detected in the cerebrospinal fluid of persons with onchocerciasis-associated epilepsy.

Authors:  An Hotterbeekx; Stephen Raimon; Gasim Abd-Elfarag; Jane Y Carter; Wilson Sebit; Abozer Suliman; Joseph Nelson Siewe Fodjo; Peter De Witte; Makoy Yibi Logora; Robert Colebunders; Samir Kumar-Singh
Journal:  Int J Infect Dis       Date:  2019-11-29       Impact factor: 3.623

9.  Nebulized ivermectin for COVID-19 and other respiratory diseases, a proof of concept, dose-ranging study in rats.

Authors:  Carlos Chaccour; Gloria Abizanda; Ángel Irigoyen-Barrio; Aina Casellas; Azucena Aldaz; Fernando Martínez-Galán; Felix Hammann; Ana Gloria Gil
Journal:  Sci Rep       Date:  2020-10-13       Impact factor: 4.379
View more
  1 in total

1.  Editorial April 2021.

Authors:  Tara L Spires-Jones
Journal:  Brain Commun       Date:  2021-04-27
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.